resTORbio to Participate at Upcoming Investor Conferences in May
SunTrust Robinson Humphrey 5th Annual Life Sciences Summit
A live audio webcast of the
resTORbio, Inc. is a clinical stage biopharmaceutical company developing innovative medicines that target the biology of aging to prevent or treat aging-related diseases. resTORbio’s lead program selectively inhibits TORC1, an evolutionarily conserved pathway that contributes to the decline in function of multiple organ systems, including the immune, cardiovascular and central nervous systems.
Stern Investor Relations, Inc.